- Home
- Personal stories
Personal stories
Bringing AI tools within reach: J&J Foundation commits $5M to support the U.S. rural health workforce
Through a coordinated $10 million investment, the Johnson & Johnson Foundation and Google.org are helping rural health workers build practical AI skills—building on J&J CareCommunity’s efforts championing nurses and community health workers.
What you need to know about Johnson & Johnson’s first-quarter 2026 earnings report
Check out this infographic breakdown of the company’s first-quarter performance, with highlights from its Innovative Medicine and MedTech businesses.
Giving the gift of sight
In Kenya, around 1.5 million people—including children—contend with visual impairment or blindness. Sight For Kids, Johnson & Johnson’s global eye-care partnership, is devoted to changing these stats, one vision screening at a time.
What are cataracts?
Cataracts are the most common cause of vision loss worldwide. Luckily a routine surgical procedure can have you viewing the world in crisp, bright color again. Here’s what to know about cataract symptoms and removal.
6 ways Johnson & Johnson is using AI to help advance healthcare
Artificial intelligence is revolutionizing healthcare—from improving surgical training and procedures to equipping healthcare providers with insights and personalizing care for patients around the world. See how the company is harnessing its extraordinary power.
Johnson & Johnson named to Fortune’s 2026 America’s Most Innovative Companies list
The company’s dedication to advancing solutions for the world’s most pressing health challenges has once again earned it a place on this annual ranking.
Meet a nurse who leads clinical trials to find innovative cancer therapies
Melissa Martinez is a clinical scientist within Johnson & Johnson’s Interventional Oncology R&D group. Not only is she helping to develop lifesaving treatments, she’s redefining what it means to pursue a career in nursing.
These Johnson & Johnson leaders are breaking new ground in healthcare
Kimberly Lounds Foster and Carmen Canovas Vidal are part of a new wave of innovators bringing their expertise in STEM into the heart of healthcare.
5 things we now know about bladder cancer
Paradigm-shifting new therapies are helping people with the disease lead longer, more comfortable lives. Learn how Johnson & Johnson is helping to change the treatment landscape.
What are alloantibodies?
Learn how Johnson & Johnson is investigating a therapy for two alloantibody-driven diseases that can affect the lives of developing fetuses and newborn babies.